Recipharm Contracted for Commercial Manufacture of ViroPharma’s Plenadren – Genetic Engineering News

ViroPharma contracted Recipharm to carry out full commercial-scale manufacture of Plenadren®, a modified release hydrocortisone drug approved in Europe in November 2011 in Europe for the treatment of adrenal insufficiency in adults. ViroPharma …